DexCom
DXCM
DXCM
725 hedge funds and large institutions have $33.1B invested in DexCom in 2021 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 289 increasing their positions, 232 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% less funds holding
Funds holding: 728 → 725 (-3)
2% less capital invested
Capital invested by funds: $33.9B → $33.1B (-$816M)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
725
Holding in Top 10
6
Calls
$455M
Puts
$451M
Top Buyers
| 1 | +$449M | |
| 2 | +$232M | |
| 3 | +$174M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$162M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$142M |
Top Sellers
| 1 | -$583M | |
| 2 | -$272M | |
| 3 | -$257M | |
| 4 |
Jennison Associates
New York
|
-$104M |
| 5 |
JPMorgan Chase & Co
New York
|
-$68.5M |